Analysed SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) News Sources
Assessing Sumitomo Pharma (TSE:4506) Valuation After A Strong Year And Recent Share Price Pullback
06-05-2026
yahoo.com
Japan Regenerative Medicine Market Trends and Forecasts to 2035 Featuring Astellas Pharma, Fujifilm, JCR Pharmaceuticals, Sumitomo Pharma, Takeda, and Terumo
13-05-2026
yahoo.com
New Data from Sumitomo Pharma America at AUA 2026 Highlight Efficacy of Vibegron in Men Aged 75 and Older with Overactive Bladder and BPH
18-05-2026
yahoo.com
Sumitomo Pharma America Presents First Clinical Data for SMP-3124LP, an Investigational PEGylated Liposome CHK1 Inhibitor, at ASCO 2026
01-06-2026
yahoo.com
Generalized Anxiety Disorder Market Forecast Shows Strong CAGR During the Forecast Period (2026-2036) Driven by Innovative Therapies | DelveInsight
04-06-2026
yahoo.com
Sumitomo Pharma America Achieves Key Patient Enrollment Milestone for Pivotal Phase 2 Study of Enzomenib in the Treatment of Relapsed/Refractory Acute Leukemia
10-06-2026
yahoo.com
What is the current price of SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS)?
The current price of SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) is $8.874.
SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) since the previous trading day is $-0.496.
SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) since the previous trading day is -5.2935%.
What is the most recent average sentiment score for SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS)?
The most recent average sentiment score for SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) is 60 out of 100.
What is the most recent average sentiment for SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS)?
The most recent sentiment for SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) is .
SEC-8K** Filing Available For SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.